Eli Lilly News

Eli Lilly's antibody drug for COVID-19 patients fails in study

Late on Monday, the National Institute of Allergy and Infectious Diseases (NIAID), ended a study into the effectiveness of Eli Lilly's antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness.

FDA found serious violations at Eli Lilly plant making Covid drug

By Karen Graham

U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly and Co. pharmaceutical plant that is ramping up to manufacture one of two promising COVID-19 drugs touted by President Trump as “a cure” for the disease.

Eli Lilly pauses Covid antibody trial over safety concerns

By Karen Graham

Eli Lilly’s phase-three trial of its ACTIV-3 monoclonal antibody treatment for coronavirus has been paused due to potential safety concerns.

New Type 2 diabetes medication shows much promise

By Ken Hanly

The global pharmaceutical company Novo Nordisk has announced that its new drug semaglutide had reduced blood glucose levels and lowered body weight to a statistically significant degree more than those treated with the competing drug dulaglutide.

Diabetes drug effective for heart attacks and stroke

By Tim Sandle

An established diabetes drug produced by pharmaceutical giant Eli Lilly has been shown to be effective against cardiovascular diseases.

Move over ADHD – is Sluggish Cognitive Tempo the next big thing?

By Martin Laine

That slow-moving, daydreaming kid who keeps forgetting to put his name on his papers might not just be overtired from staying up too late playing video games. He might be suffering from something researchers are calling Sluggish Cognitive Tempo (SCT).

Drugmakers ordered to pay $9 billion for hiding cancer risks

By Jeannie Stokowski-Bisanti

Japan's biggest pharmaceutical company has been hit with a $6 billion penalty for concealing cancer risks associated with its Actos diabetes drug while Eli Lilly and Co, Takeda's co-defendant in the case, was ordered to pay $3 billion in punitive damages.

Eli Lilly sues Canada for $500 million, citing loss of income

By Yukio Strachan

Eli Lilly, the world’s largest manufacturer of psychiatric medications, has sued Canada for $500 million, saying that allowing low-priced generic drug rivals to make two of its products cost them "hundreds of millions of dollars" in lost sales.

Eli Lilly drug thieves had 'insider knowledge'

By Tim Sandle

It is alleged that thieves who broke into the warehouse of a major pharmaceutical company in Connecticut three years ago, stealing $70 million worth of drugs, obtained inside information that revealed weaknesses in the building's security system.

Eli Lilly Reports $75 Million Drug Theft

By Martin Laine

In one the biggest heists of its kind, thieves broke into a Connecticut warehouse early Sunday morning making off with enough prescription drugs to fill a tractor-trailer. Agents from the FBI are joining local law enforcement to investigate the crime.

Eli Lilly Zyprexa Weight Gain

By DannyHaszard

Why even low dose Zyprexa causes weight gain

Set up a news alert for

Eli Lilly

Eli Lilly Image

Eli Lilly's global headquarters, Indianapolis, Indiana

Guanaco152003

It can take up to 90 days to manufacture a single batch of the active pharmaceutical ingredient and drug product for a neutralizing antibody for COVID-19. This is due to the highly complex manufacturing processes, with carefully controlled conditions and numerous quality and safety checks.

Eli Lilly and Company